dHpC tumors, including ER+ breast, ovarian, and endometrial cancers, show enriched infiltration of cytotoxic CD8+ T cells, Tregs, and myeloid subsets, alongside robust IFN and cytokine signaling. The gene discussed is CD8A; the disease is endometrial cancer.